Federated Hermes - FHI Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Federated Hermes in the last twelve months. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" FHI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FHI, but not buy additional shares or sell existing shares.
View FHI analyst ratings or view top-rated stocks.

4 Wall Street analysts have issued 1-year price objectives for Federated Hermes' stock. Their FHI share price forecasts range from $25.50 to $44.00. On average, they anticipate the company's share price to reach $36.13 in the next twelve months. This suggests that the stock has a possible downside of 11.6%.
View analysts price targets for FHI or view top-rated stocks among Wall Street analysts.

Federated Hermes' stock was trading at $36.31 on January 1st, 2023. Since then, FHI shares have increased by 12.6% and is now trading at $40.88.
View the best growth stocks for 2023 here.

Federated Hermes saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 2,370,000 shares, an increase of 8.2% from the February 13th total of 2,190,000 shares. Based on an average daily trading volume, of 622,000 shares, the days-to-cover ratio is presently 3.8 days. Currently, 2.8% of the company's shares are sold short.
View Federated Hermes' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our FHI earnings forecast.

Federated Hermes, Inc. (NYSE:FHI) issued its quarterly earnings data on Thursday, January, 26th. The company reported $0.90 EPS for the quarter, topping analysts' consensus estimates of $0.75 by $0.15. The firm earned $373.90 million during the quarter, compared to analysts' expectations of $381.41 million. Federated Hermes had a net margin of 16.57% and a trailing twelve-month return on equity of 26.80%.

Federated Hermes announced a quarterly dividend on Thursday, January 26th. Investors of record on Wednesday, February 8th will be given a dividend of $0.27 per share on Wednesday, February 15th. This represents a $1.08 dividend on an annualized basis and a yield of 2.64%. The ex-dividend date is Tuesday, February 7th.
Read our dividend analysis for FHI.

ETFs with the largest weight of Federated Hermes (NYSE:FHI) stock in their portfolio include SPDR S&P Capital Markets ETF (KCE), Cambria Shareholder Yield ETF (SYLD), Invesco S&P MidCap Low Volatility ETF (XMLV), WisdomTree U.S. SmallCap Quality Dividend Growth Fund (DGRS), Gabelli Financial Services Opportunities ETF (GABF), First Trust Active Factor Mid Cap ETF (AFMC), Invesco Russell 2000 Dynamic Multifactor ETF (OMFS) and iShares Select Dividend ETF (DVY).

Federated Hermes (NYSE:FHI) pays an annual dividend of $1.08 per share and currently has a dividend yield of 2.72%. The dividend payout ratio is 40.60%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FHI will have a dividend payout ratio of 30.25% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FHI.

Based on aggregate information from My MarketBeat watchlists, some companies that other Federated Hermes investors own include AbbVie (ABBV), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Micron Technology (MU), Tesla (TSLA), Allison Transmission (ALSN), Alexion Pharmaceuticals (ALXN), Anthem (ANTM), Arrowhead Pharmaceuticals (ARWR) and Boston Scientific (BSX).

Federated Hermes trades on the New York Stock Exchange (NYSE) under the ticker symbol "FHI."

Federated Hermes' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Schneider Downs Wealth Management Advisors LP (5.06%), Dimensional Fund Advisors LP (2.55%), Charles Schwab Investment Management Inc. (2.20%), Geode Capital Management LLC (1.91%), Victory Capital Management Inc. (1.84%) and Victory Capital Management Inc. (1.83%). Insiders that own company stock include Dolores D Dudiak, Gordon J Ceresino, John B Fisher, Meter Stephen Van, Michael J Farrell, Paul A Uhlman, Paul A Uhlman, Peter J Germain, Richard A Novak, Saker Anwar Nusseibeh and Thomas R Donahue.
View institutional ownership trends.

Shares of FHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of FHI stock can currently be purchased for approximately $40.88.

Federated Hermes (NYSE:FHI) has a market capitalization of $3.65 billion and generates $1.45 billion in revenue each year. The company earns $239.50 million in net income (profit) each year or $2.66 on an earnings per share basis.

The company employs 1,961 workers across the globe.

Federated Hermes' mailing address is 1001 LIBERTY AVENUE, PITTSBURGH PA, 15222. The official website for the company is www.federatedinvestors.com. The company can be reached via phone at (412) 288-1900, via email at investors@federatedinv.com, or via fax at 412-288-6823.